The Effect Of Sst2 On Evaluating The Pronosis Of Ckd:
A meta-analysis found that high levels of soluble ST2 (sST2) predicted all-cause and cardiovascular mortality, as well as cardiovascular events, in chronic kidney disease (CKD) patients. The study also explored the prognostic value of sST2 in end-stage renal disease (ESRD) patients and found it to be an independent predictor of survival. Additionally, sST2 has been shown to have a significant prognostic value in heart failure patients and may be a reliable biomarker in CKD patients with heart disease, regardless of kidney function.
The meta-analysis you introduced highlights the significant prognostic value of soluble ST2 (sST2) in chronic kidney disease (CKD) patients. It found that elevated levels of sST2 predicted all-cause and cardiovascular mortality, as well as cardiovascular events in CKD patients. Furthermore, the analysis suggests the independent predictive role of sST2 in the survival of end-stage renal disease (ESRD) patients. Moreover, sST2 was found to be a reliable biomarker in CKD patients with heart disease, regardless of kidney function. This indicates that sST2 has a substantial prognostic potential in evaluating the prognosis of CKD patients, including those with heart-related complications.
Sources
Related Questions
Work fast from anywhere
Stay up to date and move work forward with BrutusAI on macOS/iOS/web & android. Download the app today.